Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $40.80B | $368.36 | $387.71 | 5.25% | Strong Buy | 7 | 120.85% | 374.05% | 2,948.87% | 1,595.38% | |||
| CORT | CORCEPT THERAPEUTICS INC | $7.97B | $75.75 | $135.33 | 78.66% | Strong Buy | 3 | 29.21% | 71.83% | 144.66% | 110.99% | |||
| NVO | NOVO NORDISK A S | $218.44B | $49.16 | $60.50 | 23.07% | Buy | 4 | 94.27% | 97.06% | 507.72% | 168.38% | |||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $59.98B | $453.97 | $496.59 | 9.39% | Strong Buy | 24 | 27.95% | 234.94% | 1,319.25% | 63.60% | |||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $177.01M | $2.22 | N/A | N/A | N/A | N/A | 33.49% | 176.02% | 185.58% | 117.99% | |||
| ZVRA | ZEVRA THERAPEUTICS INC | $519.63M | $9.23 | $23.00 | 149.19% | Strong Buy | 4 | 43.39% | 47.41% | 135.83% | 66.97% | |||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $3.05B | $40.29 | $51.33 | 27.41% | Strong Buy | 6 | 20.29% | 66.99% | 41.88% | 31.47% | |||
| ARGX | ARGENX SE | $54.43B | $891.73 | $936.42 | 5.01% | Strong Buy | 12 | 1,432.04% | 11.94% | 43.65% | 37.08% | |||
| LGND | LIGAND PHARMACEUTICALS INC | $3.96B | $201.27 | $233.75 | 16.14% | Strong Buy | 4 | 4.78% | 55.67% | 23.05% | 14.83% | |||
| GMAB | GENMAB A | $19.42B | $30.24 | $43.75 | 44.68% | Strong Buy | 4 | 11.23% | 115.38% | 34.21% | 28.02% | |||
| VCEL | VERICEL CORP | $2.01B | $39.84 | $58.33 | 46.42% | Strong Buy | 3 | 17.30% | 59.36% | 26.61% | 18.89% | |||
| KRYS | KRYSTAL BIOTECH INC | $5.83B | $201.21 | $213.17 | 5.94% | Buy | 6 | 29.98% | 16.97% | 48.14% | 44.17% | |||
| RPRX | ROYALTY PHARMA PLC | $22.93B | $39.73 | $46.00 | 15.78% | Strong Buy | 3 | 12.40% | 47.82% | 41.62% | 20.69% | |||
| TECH | BIO-TECHNE CORP | $9.47B | $60.75 | $71.11 | 17.06% | Strong Buy | 9 | 6.45% | 71.51% | 19.96% | 15.53% | |||
| CRMD | CORMEDIX INC | $883.23M | $11.21 | $18.40 | 64.14% | Buy | 5 | 27.53% | 3.95% | 56.75% | 28.28% | |||
| HALO | HALOZYME THERAPEUTICS INC | $8.37B | $71.19 | $80.14 | 12.58% | Buy | 7 | 16.43% | 26.49% | 241.29% | 54.74% | |||
| MDXG | MIMEDX GROUP INC | $1.11B | $7.47 | $12.00 | 60.64% | Strong Buy | 1 | 5.43% | 21.04% | 29.08% | 21.78% | |||
| GYRE | GYRE THERAPEUTICS INC | $778.37M | $8.08 | $17.00 | 110.40% | Strong Buy | 2 | 14.35% | 17.03% | 213.06% | 136.25% | |||
| VCYT | VERACYTE INC | $3.15B | $39.87 | $44.17 | 10.78% | Buy | 6 | 7.53% | 45.50% | 12.87% | 11.83% | |||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $10.42B | $54.22 | $87.10 | 60.64% | Strong Buy | 10 | 6.52% | 25.68% | 22.06% | 17.54% | |||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.97B | $34.29 | $46.14 | 34.57% | Strong Buy | 7 | 11.03% | 17.26% | 71.07% | 49.12% | |||
| INCY | INCYTE CORP | $20.69B | $105.41 | $92.29 | -12.45% | Buy | 14 | 8.31% | 14.06% | 42.39% | 31.15% | |||
| AUPH | AURINIA PHARMACEUTICALS INC | $2.01B | $15.22 | $17.67 | 16.08% | Buy | 3 | 11.00% | 17.33% | 41.64% | 28.87% | |||
| EXEL | EXELIXIS INC | $11.35B | $42.35 | $45.84 | 8.25% | Buy | 19 | 9.96% | 14.04% | 57.84% | 44.26% | |||
| ADMA | ADMA BIOLOGICS INC | $3.74B | $15.70 | N/A | N/A | N/A | N/A | 19.43% | 12.65% | 89.24% | 67.66% | |||
| VRTX | VERTEX PHARMACEUTICALS INC | $110.25B | $434.52 | $480.05 | 10.48% | Buy | 19 | 7.51% | 16.73% | 35.88% | 25.00% | |||
| INVA | INNOVIVA INC | $1.66B | $22.20 | $32.00 | 44.14% | Buy | 4 | 6.97% | 10.15% | 23.03% | 16.28% | |||
| UTHR | UNITED THERAPEUTICS CORP | $19.91B | $462.30 | $495.08 | 7.09% | Buy | 12 | 5.75% | 2.59% | 24.64% | 22.09% | |||
| CPRX | CATALYST PHARMACEUTICALS INC | $2.83B | $23.02 | $33.00 | 43.35% | Strong Buy | 1 | 5.30% | 0.59% | 48.64% | 42.56% | |||
| MNKD | MANNKIND CORP | $1.56B | $5.07 | $10.30 | 103.16% | Strong Buy | 5 | 12.01% | 18.57% | -235.51% | 21.21% | |||
| REGN | REGENERON PHARMACEUTICALS INC | $73.04B | $694.99 | $741.79 | 6.73% | Strong Buy | 14 | 4.92% | 5.91% | 19.37% | 14.93% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.